How Medicare Part D Coverage Works for Weight Loss Medications
Medicare Part D is a prescription drug coverage program that helps pay for medications. It is optional coverage that beneficiaries can choose to add to their Medicare plan. Part D plans are offered by private insurance companies approved by Medicare, and they vary in what drugs they cover and how much they cost.
Free Guide to Senior Services and Programs in Your Area →
Weight loss medications have become a subject of increased interest within Part D coverage discussions. These medications—including GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro)—were originally developed to treat type 2 diabetes. In recent years, versions of these drugs received approval for weight management in people without diabetes. This has raised questions about whether Medicare Part D will cover them for weight loss purposes specifically.
Each Part D plan creates a list of covered medications called a formulary. Insurance companies decide which drugs to include, at what tier (cost level), and with what restrictions. A drug being on the formulary means the plan will help pay for it. However, being on a formulary does not mean there are no limitations. Plans may require prior authorization (approval before filling the prescription), may limit how much they will pay, or may restrict how often you can refill the medication.
The key distinction for weight loss drugs involves FDA approval status and indication. Medications approved specifically for weight management may be treated differently than the same medications approved for diabetes. Some Part D plans may cover a weight loss drug while others do not. This varies considerably among the thousands of Part D plans available.
Practical takeaway: Weight loss medications may or may not be covered by your specific Part D plan. To learn whether your plan covers a particular medication, you can review your plan's formulary (usually available on the insurance company's website) or contact your plan directly.
Current Coverage Status of Popular Weight Loss Medications
As of early 2024, Medicare Part D coverage of weight loss medications remains inconsistent. GLP-1 receptor agonists represent the most commonly prescribed class of weight loss drugs. This class includes semaglutide, tirzepatide, and liraglutide. These medications work by regulating appetite signals in the brain and slowing stomach emptying, leading to reduced food intake and weight loss.
Your Free Guide to Berkey Water Filter Care →
Semaglutide carries FDA approval under two brand names: Ozempic (for type 2 diabetes) and Wegovy (for weight management). Many Part D plans cover Ozempic because it treats diabetes, which is a covered medical condition. However, many plans do not cover Wegovy because it is labeled solely for weight loss in non-diabetic individuals. This means your plan may cover the same medication under one brand name but not the other, depending on the indication for which it was prescribed.
Tirzepatide was approved first under the brand name Mounjaro for type 2 diabetes. Later, the FDA approved tirzepatide under the brand name Zepbound specifically for weight management. Similar to semaglutide, Part D plans are more likely to cover tirzepatide for diabetes than for weight loss alone. However, coverage decisions vary widely among plans and insurance companies.
Other weight loss medications with longer histories include phentermine (an amphetamine-like stimulant approved decades ago) and orlistat (which works in the digestive system rather than the brain). Phentermine is sometimes covered by Part D plans, though often with restrictions to short-term use. Orlistat is available both by prescription and over-the-counter, so Part D coverage may not be necessary for the over-the-counter version.
Coverage data shows that as of 2023-2024, approximately 4 in 10 Medicare beneficiaries had access to at least one GLP-1 medication through their Part D plan. However, this varies by plan and region. Some plans cover these medications liberally while others restrict them significantly or exclude them entirely.
Practical takeaway: Check your specific plan's formulary to see if a weight loss medication you are considering is covered. The name of the medication and its approved use (indication) both matter for coverage decisions.
Understanding Prior Authorization and Coverage Restrictions
Prior authorization (sometimes called "prior approval") is a process where your doctor's office must contact your insurance plan before you fill a prescription. The doctor submits medical information justifying why you need the medication. The insurance plan then decides whether to approve it. This process can delay treatment while the paperwork is being reviewed, typically taking several business days.
Create Your Own Email Account Guide →
Many Part D plans that do cover weight loss medications require prior authorization. This means that even though the medication is on the formulary, you cannot simply have it filled at the pharmacy. Your prescriber must go through the approval process first. The insurance plan may ask for documentation showing that you have tried other weight loss methods, your current body mass index (BMI), any obesity-related health conditions you have, and why your doctor believes this particular medication is appropriate for you.
Step therapy is another common restriction. This means the insurance plan requires you to try one or more other medications before covering the one your doctor wants to prescribe. For weight loss, a plan might require you to try a less expensive medication first before covering a GLP-1 medication. If the first medication does not work or causes unacceptable side effects, you can return to the plan with documentation, and they may then approve the second medication.
Quantity limits are restrictions on how much of a medication you can receive in a given time period. Since weight loss medications like semaglutide and tirzepatide come in injectable form with specific dosing schedules, quantity limits typically restrict how many pens or vials you receive per month or year. A plan might limit coverage to one pen per month, which matches the standard dosing schedule, or might limit it to fewer doses.
Failure to obtain prior authorization before filling a prescription can result in the claim being denied at the pharmacy, leaving you to pay the full cost out of pocket. It can also result in coverage denial after the fact, even if you have already paid and received the medication.
Practical takeaway: Before getting a prescription filled for a weight loss medication, ask your doctor's office to check with your insurance plan about prior authorization requirements. This prevents surprises at the pharmacy counter.
Cost Considerations and Out-of-Pocket Expenses
Even when a weight loss medication is covered by Part D, you will likely have out-of-pocket costs. Part D plans use a cost-sharing structure with multiple stages throughout the year. Understanding this structure helps you predict what you might pay.
Learn About Tax Refunds and SSI Benefits →
The deductible is what you pay out of pocket before your insurance plan begins to help pay. As of 2024, the standard Part D deductible is $545 per year (this amount changes annually). Some plans have no deductible, while others have higher deductibles. Once you reach your deductible, cost-sharing typically shifts to copayments or coinsurance.
Copayments are fixed amounts you pay per prescription. For example, you might pay $25 per injection or vial of a weight loss medication. Coinsurance means you pay a percentage of the medication's cost, such as 20% or 25%. Which structure your plan uses depends on the specific plan and the tier assigned to the medication.
Medications are typically divided into tiers based on cost. Tier 1 includes generic drugs and is usually least expensive to you. Tier 2 includes preferred brand-name drugs. Tier 3 includes non-preferred brand-name drugs and typically costs more. Tier 4 or higher tiers may include specialty drugs, which can have very high out-of-pocket costs. Weight loss medications, being relatively new and expensive, are often placed in higher tiers.
The coverage gap (sometimes called the "donut hole") is another feature of Part D. Once you and your plan have spent a combined $5,221 on covered drugs in 2024, you enter the coverage gap. In the gap, you pay a higher percentage of medication costs until your out-of-pocket spending reaches $8,550 (this threshold changes annually). At that point, you enter catastrophic coverage and costs decrease again. However, not all medications affect the out-of-pocket threshold equally—manufacturer discounts may apply.
Brand-name weight loss medications can cost $1,000 to $1,500 per month without insurance. Even with Part D coverage, if the drug is in a high tier,